Lactic acid bacterium potently induces the production of interleukin-12 and interferon-γ by mouse splenocytes

https://doi.org/10.1016/S0192-0561(98)00072-1Get rights and content

Abstract

We previously have reported that the lactic acid bacterium, Lactobacillus casei strain Shirota (LcS), shows marked antitumor activities and an ability to modify immune responses. In this study, we examined whether LcS can induce the production of interleukin (IL)-12 and interferon-gamma (IFN-γ), which are important cytokines for antitumor and antimicrobial immunity, from murine splenocytes in vitro in order to clarify the mechanisms of its immune modification.

Stimulation by LcS induced a marked production of IL-12 by X-ray-irradiated splenocytes (X-irr-Spl). The production of IL-12 by X-irr-Spl was independent of the presence of nylon wool column-passed splenocytes (NW-Spl). IFN-γ was produced by splenocytes by the stimulation with concanavalin A (Con A). LcS showed a synergistic stimulatory effect on the ConA-induced production of IFN-γ. In addition, X-irr-Spl were required for the IFN-γ production by NW-Spl treated with LcS. The IFN-γ production was reduced by anti-IL-12 antibody treatment. NW-Spl produced IFN-γ following treatment with recombinant IL-12. Thus, we confirmed that IFN-γ production by splenocytes was the result of the production of IL-12 from X-irr-Spl stimulated by LcS. Furthermore, in BALB/c mice, the oral administration of viable LcS augmented the production of IFN-γ but not that of IL-4 or IL-5 by splenocytes.

Thus, we suggested that LcS primarily activated X-irr-Spl, probably macrophages, and these cells secreted IL-12. The IL-12 induced by LcS stimulated the production of IFN-γ.

Introduction

Interleukin (IL)-12 is an important cytokine for inducing cellular immunity. IL-12 potently stimulates cytotoxic T cells and natural killer (NK) cells, and enhances the production of Th1 cytokines (IL-2 and interferon-gamma (IFN-γ)) and the proliferation of Th1 cells. IL-12 is secreted by B cells, dendritic cells, and macrophages. IL-12 has potent in vivo antitumor and anti-metastatic effects against murine tumors via cytotoxicity of CD8+ T cells and IFN-γ production from helper T cells. Some microorganisms (Song et al., 1996; Chong et al., 1996; Fujimoto et al., 1997) and their cellular components (DAndrea et al., 1992; Wysocka et al., 1995) induce IL-12 production. The production of cytokines from Th1 T cells was shown to be coincident with the activation of tumor-specific T cells (Goedegebuure et al., 1997).

IFN-γ has multiple functions in a host. It mainly augments cellular immunities, namely antitumor and anti-infection responses. IFN-γ also inhibits the production of Th2 cytokines such as IL-4 and IL-5. The inhibition of Th2 cytokines leads to the diminution of specific humoral immune responses to antigens.

It is well known that lactic acid bacteria and their products have beneficial effects on the health of animals and humans by reports from many investigators (Shahani et al., 1983; Davidkova et al., 1992; Popova et al., 1993; Perdigon et al., 1993; Pereyra and Lemonnier, 1993). The lactic acid bacterium, Lactobacillus casei strain Shirota (LcS), has immunomodulatory effects in hosts, and has shown marked antitumor activity in experimental animals and humans (Masuno et al., 1991; Aso et al., 1992; Aso et al., 1995;Okawa et al., 1989; Kato, Kobayashi, Yokokura and Mutai, 1981; Matsuzaki et al., 1987; Matsuzaki et al., 1988). We also demonstrated that the immune response mediated by T cells were suppressed in tumor-bearing mice: the levels of splenic T-cell responses (i.e. cell proliferation responses against IL-1, IL-2, phytohemaggulutinin and Con A) in tumor-bearing mice was restored to the normal level by the oral administration of LcS (Kato et al., 1994). Shimizu et al., 1981demonstrated that LcS did not show the direct mitogenic effect on T cells. LcS augments NK activity and T-cell-mediated tumor immunity and directly activates macrophage functions (Kato et al., 1983, Kato et al., 1984, Kato et al., 1988; Yasutake et al., 1984). Generally, cellular immunity plays an important role in the antitumor activity and is augmented by Th1 cytokines (e.g. IFN-γ). And IL-12 augment the production of Th1 cytokines, and restrict the production of Th2 cytokines. IL-12 and IFN-γ are key cytokines in the acquisition of non-specific and antigen-specific cellular immunity. Thus, in the present study, we examined the effect of LcS on the production of IL-12 and IFN-γ.

Section snippets

Mice

Inbred male BALB/c mice were purchased from SLC Japan (Hamamatsu, Japan), and used at 7–10 weeks of age. The mice were housed in plastic cages in a room kept at 24±2°C and 55±5% humidity, on a 12 h light/dark cycle under pathogen-free conditions. They were allowed food and water ad libitum.

Microorganisms

For the in vitro experiments, heat-killed LcS was used. LcS was cultured for 24 h at 37°C in Rogosa medium, collected by centrifugation, and washed with sterile distilled water. And this organism was killed

IL-12 production induced by LcS

X-irr-Spl were cultured with LcS, and the contents of IL-12 in the culture supernatant were determined by ELISA. IL-12 could be detected at 6 h after the addition of LcS. After 24 h, the production of IL-12 was markedly increased by the stimulation of LcS. The increase of IL-12 continued for 48 h. No spontaneous release of IL-12 from X-irr-Spl was detected (Table 1). As shown in Fig. 1, X-irr-Spl alone produced IL-12 following exposure to LcS. To examine the influences of T cells on the

Discussion

Some microorganisms that possess antitumor activity (e.g. Mycobacterium bovis BCG and Streptococcus pyogenes) can induce IL-12 production in macrophages (Fujimoto et al., 1997). Listeria monocytogenes (Song et al., 1996), Salmonella (Chong et al., 1996) and lipoteichoic acid from gram-positive bacteria (Cleveland et al., 1996) also potentiate IL-12 production. In the present study, we found that LcS is a potent inducer of IL-12. X-ray-resistant splenocytes from BALB/c mice produced IL-12 after

References (30)

  • Aso, Y., Akaza, H., and BLP study group (1992). Prophylactic effect of a Lactobacillus casei preparation of the...
  • Aso, Y., Akaza, H., Kotake, T., Tsukamoto, T., Imai, K., Naito, S., and BLP study group (1995). Preventive effect of a...
  • Bottomly, K. (1988). A functional dichotomy in CD4+ T lymphocytes. Immunol.Today, 9,...
  • Chong, C., Bost, K. L., and Clements, J. D. (1996). Differential production of interleukin-12 mRNA by murine...
  • Cleveland, M. G., Gorham, J. D., Murphy, T. L., Toumanen, E., and Murphy, K. M. (1996). Lipoteichoic acid preparations...
  • DAndrea, A., Rengaraju, M., Valiante, N. M., Chehimi, J., Kubin, M., Aste, M., Chan, S. H., Kobayashi, M., Young, D.,...
  • Davidkova, G., Popova, P., Guencheva, G., Bogdanov, A., Pacelli, E., Auteri, A., Mincheva, V. (1992). Endogenous...
  • Fujimoto, T., Duda, R. B., Szilvasi, A., Chen, X. H., Mai, M., and ODonnell, M. A. (1997). Streptococcal preparation...
  • Garside, P., and Mowat, A. M. (1995). Polarization of Th-cell responses: a phylogenetic consequence of non-specific...
  • Goedegebuure, P. S., Douville, C. C., Doherty, J. M., Lineham, D. C., Lee, K.-Y., Ganguly, E. K., and Eberlein, T. J....
  • Hsieh C.-S., Macatonia, S. E., OGarra, A., and Murphy, K. M. (1993). Pathogen induced Th1 phenotype development in CD4+...
  • Kato, I., Endo, K., and Yokokura, T. (1994). Effect of oral administration of Lactobacillus casei on antitumor...
  • Kato, I., Kobayashi, S., Yokokura, T., and Mutai, M. (1981). Antitumor effect of Lactobacilluscasei in mice. Gann, 72,...
  • Kato, I., Yokokura, T., and Mutai, M. (1984). Augmentation of mouse natural killer cell activity by Lactobacillus casei...
  • Kato, I., Yokokura, T., and Mutai, M. (1988). Correlation between increase in Ia-bearing macrophages and induction of T...
  • Cited by (166)

    • Distribution, cholesterol-lowering and immunomodulation effects of lactic acid bacteria from fermented mussel (Hoi-dong)

      2022, Heliyon
      Citation Excerpt :

      The NO-induced production of LAB in this examination is similar to earlier publications (Kmonickova et al., 2012; Korhonen et al., 2001; Surayot et al., 2014). As a consequence, these isolates have the potential to be effective against invading pathogens via stimulation immunity (Kang et al., 2021a,b; Kato et al., 1999). Surprisingly, the heat-killed cells in this study still had immunomodulation activities; hence, the benefits of inactive cells include a lower risk of antibiotic resistance and sepsis and an extension of life span since there is no requirement to retain the viability (Shripada et al., 2020; Zendeboodi et al., 2020).

    • Oral vaccination with invasive Lactobacillus plantarum delivered nucleic acid vaccine co-expressing SS1 and murine interleukin-4 elicits protective immunity against Trichinella spiralis in BALB/c mice

      2021, International Immunopharmacology
      Citation Excerpt :

      Some of LAB are non-pathogenic probiotics that have beneficial effects against parasite infections [8]. L. plantarum could tolerate acid and bile salts and adhere to intestinal epithelial cells, allowing it to permanently colonize the intestine [28]. Another study reported that oral inoculation with the probiotic Lactiplantibacillus casei markedly reduced adult worm and muscle larva burden in T. spiralis-infected mice [29].

    • Targeted delivery of probiotics to enhance gastrointestinal stability and intestinal colonisation

      2017, International Journal of Pharmaceutics
      Citation Excerpt :

      Gastrointestinal health claims attributed to probiotics include the alleviation of lactose intolerance, prevention of antibiotic-associated diarrhoea, and management of inflammatory bowel disease (Tung et al., 2009; Vasiljevic and Shah, 2008; Gismondo et al., 1999; Guslandi et al., 2003; Mimura et al., 2004). Probiotics have also been reported to have roles in immune stimulation and modulation as well as in the management of obesity (Morita et al., 2002; Kato et al., 1999). Some probiotics have been reported to have anti-carcinogenic and cholesterol-lowering properties (Couteau et al., 2001; Tabuchi et al., 2003).

    • PROBIOTICS AND IMMUNE RESPONSE IN DISEASE PREVENTION AND TREATMENT

      2024, Immune-Boosting Nutraceuticals for Better Human Health: Novel Applications
    View all citing articles on Scopus
    View full text